Valuation: Dian Diagnostics Group Co.,Ltd.

Capitalization 1.67TCr 240.03Cr 204.15Cr 189.22Cr 176.83Cr 329.64Cr 22TCr 349.39Cr 2.16TCr 858.54Cr 10TCr 900.04Cr 881.63Cr 38TCr P/E ratio 2025 *
156x
P/E ratio 2026 * 34.4x
Enterprise value 1.56TCr 223.54Cr 190.12Cr 176.22Cr 164.68Cr 306.99Cr 21TCr 325.38Cr 2.01TCr 799.55Cr 9.7TCr 838.2Cr 821.05Cr 35TCr EV / Sales 2025 *
1.54x
EV / Sales 2026 * 1.5x
Free-Float
65.54%
Yield 2025 *
0.19%
Yield 2026 * 0.71%
More valuation ratios * Estimated data
Dynamic Chart
23/25/23 Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
20/25/20 Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
04/25/04 Dian Diagnostics Group Co.,Ltd. Approves A Shares Cash Dividend for the Year 2024, Payable on June 18, 2025 CI
29/25/29 UOB Kay Hian Downgrades Dian Diagnostics Group to Sell from Hold, Price Target is 10.50 Yuan MT
28/25/28 Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
23/25/23 Dian Diagnostics Group Co.,Ltd. Proposes Final Dividend for the Year 2024 CI
22/25/22 Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
13/24/13 Dian Diagnostics Group Co.,Ltd.(SZSE:300244) dropped from Shenzhen Stock Exchange Component Index CI
13/24/13 Dian Diagnostics Group Co.,Ltd.(SZSE:300244) dropped from Shenzhen Stock Exchange Component A Share Index CI
31/24/31 Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI
30/24/30 Dian Diagnostics Group Co.,Ltd.'s Equity Buyback announced on February 7, 2024, has closed with 13,880,000 shares, representing 2.23% for CNY 199.55 million. CI
09/24/09 Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
09/24/09 Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI
More news
1 day+3.68%
1 week-5.69%
Current month+72.56%
1 month+73.54%
3 months+79.82%
6 months+75.66%
Current year+72.56%
More quotes
1 week 24.78
Extreme 24.78
28.27
1 month 15.35
Extreme 15.35
33.3
Current year 15.87
Extreme 15.87
33.3
1 year 10.45
Extreme 10.45
33.3
3 years 8.9
Extreme 8.9
33.3
5 years 8.9
Extreme 8.9
52.38
10 years 8.9
Extreme 8.9
52.38
More quotes
Manager TitleAgeSince
Director of Finance/CFO 58 29/08/2023
Director of Finance/CFO 57 21/07/2017
Corporate Officer/Principal 67 30/09/2020
Director TitleAgeSince
Chairman 57 01/01/1996
Director/Board Member 51 27/09/2019
Chairman 51 13/12/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.68%-5.69%+161.72%-0.51% 231.2Cr
+0.24%+5.02%+41.35%+461.79% 3.36TCr
-0.77%+0.26%-16.73%-25.79% 794.51Cr
+0.23%+3.01%+12.59%+252.09% 563.93Cr
-0.79%-6.90%+29.56%+667.84% 294.48Cr
-2.93%-2.40%-3.17%+30.72% 258.68Cr
+2.01%-6.78%+36.08%-61.31% 218.39Cr
-2.33%+1.82% - - 189.47Cr
-2.16%-1.02%-13.64%+6.03% 167.82Cr
+4.93%+9.01%+47.03%+21.21% 169.6Cr
Average +0.15%+1.43%+32.75%+150.23% 624.8Cr
Weighted average by Cap. +0.08%+1.00%+31.62%+308.48%
See all sector performances

Financials

2025 *2026 *
Net sales 1.01TCr 145.02Cr 123.34Cr 114.32Cr 106.83Cr 199.15Cr 13TCr 211.08Cr 1.31TCr 518.69Cr 6.29TCr 543.76Cr 532.64Cr 23TCr 1.1TCr 157.61Cr 134.04Cr 124.25Cr 116.11Cr 216.44Cr 14TCr 229.41Cr 1.42TCr 563.73Cr 6.84TCr 590.98Cr 578.89Cr 25TCr
Net income 12Cr 1.68Cr 1.43Cr 1.32Cr 1.24Cr 2.3Cr 154.13Cr 2.44Cr 15Cr 6Cr 73Cr 6.29Cr 6.16Cr 264.72Cr 50Cr 7.13Cr 6.06Cr 5.62Cr 5.25Cr 9.79Cr 654.76Cr 10Cr 64Cr 25Cr 309.15Cr 27Cr 26Cr 1.12TCr
Net Debt -114.84Cr -16Cr -14Cr -13Cr -12Cr -23Cr -1.52TCr -24Cr -148.59Cr -59Cr -715.44Cr -62Cr -61Cr -2.6TCr -30Cr -4.34Cr -3.69Cr -3.42Cr -3.2Cr -5.96Cr -398.73Cr -6.32Cr -39Cr -16Cr -188.26Cr -16Cr -16Cr -684.82Cr
More financial data * Estimated data
Logo Dian Diagnostics Group Co.,Ltd.
Dian Diagnostics Group Co Ltd is a China-based company primarily engaged in the provision of comprehensive medical diagnosis solutions. The Company's main business is the provision of disease-oriented in vitro diagnostic products and medical testing services to various general hospitals and specialized hospitals, physical examination centers, disease prevention and control centers and other medical institutions. The Company's main business involves medical diagnostic services, diagnostic technology research and development, diagnostic product production and sales, contract research organization (CRO), forensic identification, health management and other fields. The Company’s medical tests include molecular diagnosis, pathological diagnosis, biochemical luminescence testing, immunological testing, physical and chemical mass spectrometry testing and other comprehensive tests. The Company conducts its business in the domestic market.
Employees
8,773
More about the company
Date Price Change Volume
23/26/23 27.35 ¥ +3.68% 8,55,48,090
22/26/22 26.38 ¥ -0.30% 5,70,48,790
21/26/21 26.46 ¥ +5.59% 7,96,30,150
20/26/20 25.06 ¥ -2.19% 6,91,40,840
19/26/19 25.62 ¥ +1.39% 7,43,47,010

End-of-day quote Shenzhen S.E., January 23, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
27.35CNY
Average target price
15.20CNY
Spread / Average Target
-44.41%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300244 Stock